Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD–Positive AML
Megan E. Zavorka Thomas(The Ohio State University), Sharyn D. Baker(The Ohio State University)
Cited by 45
Related Papers
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03)
|Pediatric Blood & Cancer|2017|73
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
|Nature Communications|2019|41
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
|Journal of Clinical Investigation|2017|39